H.C. Wainwright reiterates Phathom stock rating on strong revenue growth — See source for full details.
$PHAT
Price history, market instrument context, member research, and related headlines in one place.
PHAT key statistics
NasdaqGSUSD
52-week range
$6.528%$18.31
Latest session $7.42–$7.69Phathom Pharmaceuticals, Inc. (PHAT) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $7.45, up $0.05 (0.68%) from the previous close of $7.40. It has traded between $7.42 and $7.69 in the latest session. Over the past year it has ranged from $6.52 to $18.31, leaving it in the lower quarter of its 52-week range (8%). Reported volume for the session was 261.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Phathom forecasts $310M-$325M 2026 revenue while planning Phase 3 as-needed GERD trial in Q4 — See source for full details.
Loading $PHAT research…